Development of humoral and cellular immunological memory against SARS-CoV-2 despite B-cell depleting treatment in multiple sclerosis. Asplund Högelin et al.

Published: 24 August 2021| Version 1 | DOI: 10.17632/59z3rn4x6p.1
Contributor:
Faiez Al Nimer

Description

Supplementary Table 1. Detailed characteristics of the study cohort.

Files

Categories

Immunology, Rituximab, Multiple Sclerosis, COVID-19

Licence